Diffuse large B-cell lymphoma (DLBCL), an aggressive form of blood cancer, currently poses significant treatment challenges, especially among older patients...

In the complex landscape of end-of-life (EOL) care for patients with advanced cancer, a critical factor that often goes underexamined...

In a groundbreaking leap for cancer research, a team of scientists has successfully engineered a sophisticated 3D pentaculture model that...

Chronic inflammation has long been recognized as a pivotal contributor to cancer development, yet the mechanistic pathways bridging persistent inflammatory...

A groundbreaking study conducted by the Garvan Institute of Medical Research has unveiled the most intricate cellular map of early-stage...

In a groundbreaking study published in the British Journal of Cancer this March, researchers have unveiled compelling insights into how...

In the evolving landscape of cancer treatment, type I interferons (IFNs) have emerged as pivotal players in modulating the immune...

In a groundbreaking development presented at the 15th European Breast Cancer Conference (EBCC15) in Barcelona, new evidence has emerged that...

In a groundbreaking new study, researchers have unveiled an intricate molecular mechanism by which the oncogene MYCN impedes differentiation in...

In the realm of cancer research, scientific discourse often intersects with societal beliefs, particularly concerning the impact of psychosocial factors...